GLYCEMIC OUTCOMES AND SAFETY WITH MINIMED 780G SYSTEM IN CHILDREN WITH TYPE 1 DIABETES AGED 2-6 YEARS

被引：0
|
作者：
Tuomaala, A. -K. [1 ]
Varimo, T. [1 ]
Hakonen, E. [1 ]
Kiiveri, S. [1 ]
Janer, J. [1 ]
Hyvonen, M. [1 ]
Wehkalampi, K. [1 ]
Laakkonen, H. [1 ]
Laakso, S. [1 ]
Harsunen, M. [1 ]
Hero, M. [1 ]
Miettinen, P. [1 ]
Pulkkinen, M. -A. [1 ]
机构：
[1] Helsinki Univ Hosp, HUS, Pediat & Adolescence, Helsinki, Finland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP005 / #1
引用
收藏
页码：A82 / A82
页数：1
相关论文
共 50 条
  • [41] Clinical outcomes with MiniMedtm 780g advanced hybrid closed-loop therapy in children <7 years with type 1 diabetes
    Uslu, N. Gul
    Kizilay, D. Ozalp
    Demir, G.
    Altinok, Y. Atik
    Darcan, S.
    Ozen, S.
    Goksen, D.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 123 - 124
  • [42] Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy In Children <7 years with Type 1 Diabetes
    Uslu, Nihal Gul
    Kizilay, Deniz Ozalp
    Demir, Gunay
    Altinok, Yasemin Atik
    Darcan, Sukran
    Ozen, Samim
    Goksen, Damla
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 356 - 357
  • [43] Simplified meal announcement and its characteristics in adolescents with type 1 diabetes using MiniMed 780g for one year
    Petrovski, G.
    Campbell, J.
    Pasha, M.
    Hussain, K.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 76 - 76
  • [44] MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control
    Lombardo, Fortunato
    Passanisi, Stefano
    Alibrandi, Angela
    Bombaci, Bruno
    Bonfanti, Riccardo
    Delvecchio, Maurizio
    Di Candia, Francesca
    Mozzillo, Enza
    Piccinno, Elvira
    Piona, Claudia Anita
    Rigamonti, Andrea
    Scialabba, Francesco
    Maffeis, Claudio
    Salzano, Giuseppina
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (06) : 404 - 413
  • [45] Expert panel opinion on the optimal educational pathway for diabetes educators for training people with type 1 diabetes on the MiniMed™ 780G system: a Delphi consensus
    Geraldine, Gallen
    Alice, Rosso
    Nuria, Alonso-Carril
    Sima, Arbeli
    Virginie, Bahon
    Vanessa, Brown
    Kerstin, Endlich
    Francesca, Gulotta
    Audrey, Hansart
    Amy, Jolley
    Rea, Jussila
    Anna, Stefanowicz-Bielska
    Paola, Cardano
    ACTA DIABETOLOGICA, 2024,
  • [46] Real world efficacy and safety of the advanced hybrid closed-loop system MiniMed 780G (SmartGuard) in children under 7 years of age
    Lopez-Lopez, Sara
    Diaz-Martin, Cristina
    Garcia-de Pablo, Ines
    Ovejero-Garcia, Maria Teresa
    Garnier-Rodriguez, Maria Beatriz
    Molina-Suarez, Ruth
    Ontoria-Betancort, Cristina
    Saez-Gallego, Blanca
    Dominguez-Garcia, Angela
    Quinteiro-Gonzalez, Sofia
    Travieso-Suarez, Lourdes
    Cabrera-Guedes, Maria Fatima
    Novoa-Medina, Yeray
    FRONTIERS IN MEDICINE, 2025, 11
  • [47] SAFETY AND GLYCEMIC OUTCOMES OF MINIMED™ 780G ADVANCED HYBRID CLOSED LOOP SYSTEM IN ADOLESCENTS AND ADULTS WITH T1DM DURING RAMADAN FASTING: A RANDOMIZED CONTROLLED TRIAL
    Elbarbary, N.
    Ismail, E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A113 - A113
  • [48] The impact of MiniMeD™ 780 g on the sleep quality among caregivers of children with type 1 diabetes
    Elhenawy, Y.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 247 - 247
  • [49] MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targets
    Smaniotto, Vittorino
    Heller, Simon
    O'Neal, David
    Jendle, Johan
    Cukierman-Yaffe, Tali
    Arrieta, Arcelia
    Thijs, Isabeau
    Castaneda, Javier
    van den Heuvel, Tim
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2242 - 2250
  • [50] Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed-loop system: A randomized controlled trial
    Elbarbary, Nancy Samir
    Ismail, Eman Abdel Rahman
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 191
12345